Literature DB >> 19674103

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

Can-Jie Guo1, Qin Pan, Tao Cheng, Bo Jiang, Guang-Yu Chen, Ding-Guo Li.   

Abstract

Activation of hepatic stellate cells (HSCs), which is regulated by multiple signal transduction pathways, is the key event in liver fibrosis. Moreover, members of these pathways are important targets for microRNAs (miRNAs). To better understand the critical pathways of HSC activation, we performed comprehensive comparative bioinformatics analysis of microarrays of quiescent and activated HSCs. Changes in miRNAs associated with HSC activation status revealed that 13 pathways were upregulated and 22 pathways were downregulated by miRNA. Furthermore, mitochondrial integrity, based on highly upregulated Bcl-2 and downregulated caspase-9, was confirmed in HSCs and fibrotic livers by immnofluorescence assay, quantitative RT-PCR, and western blot analysis. These findings provide in vitro and in vivo evidence that the mitochondrial pathway of apoptosis plays a significant role in the progression of liver fibrogenesis via HSC activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674103     DOI: 10.1111/j.1742-4658.2009.07213.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

Review 1.  Emerging role of microRNAs in liver diseases.

Authors:  Shashi Bala; Miguel Marcos; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

2.  miRNA studies in in vitro and in vivo activated hepatic stellate cells.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Jinmiao Chen; Henry Yang; Lang Zhuo
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 3.  Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Authors:  Elisabetta Mormone; Joseph George; Natalia Nieto
Journal:  Chem Biol Interact       Date:  2011-07-22       Impact factor: 5.192

Review 4.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

5.  The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes.

Authors:  Agata Page; Derek A Mann; Jelena Mann
Journal:  Curr Pathobiol Rep       Date:  2014-09-27

6.  Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.

Authors:  Yaqin Zhang; Linping Wu; Yang Wang; Mingcao Zhang; Limin Li; Dihan Zhu; Xihan Li; Hongwei Gu; Chen-Yu Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

7.  Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.

Authors:  Sarmistha Bandyopadhyay; Robin C Friedman; Rebecca T Marquez; Kathy Keck; Benjamin Kong; Michael S Icardi; Kyle E Brown; Christopher B Burge; Warren N Schmidt; Yulei Wang; Anton P McCaffrey
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

Review 8.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

9.  Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.

Authors:  Fang Wang; Ling Li; Klaus Piontek; Masazumi Sakaguchi; Florin M Selaru
Journal:  Hepatology       Date:  2018-01-29       Impact factor: 17.425

10.  Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKβ-deficient mouse.

Authors:  Jeongeun Hyun; Steve S Choi; Anna Mae Diehl; Youngmi Jung
Journal:  J Mol Histol       Date:  2013-08-15       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.